Marketing-authorisation holder · United States
Legacy Pharma
21 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
21 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
21 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALA-SCALP2% · Lotion | Hydrocortisone | United States | Marketed | 1973 |
| BETAPACE120mg | 160mg | 240mg | 320mg | 80mg · Tablet | Sotalol | United States | Marketed | 1992 |
| BETAPACE AF100mg | 120mg | 160mg | 40mg | 60mg | 80mg · Tablet | Sotalol | United States | Marketed | 2000 |
| BRISDELLE7.5mg base · Capsule | Paroxetine | United States | Marketed | 2013 |
| CLODERM0.1% · Cream | Clocortolone pivalate | United States | Marketed | 1977 |
| CROTAN10% · Lotion | Crotamiton | United States | Marketed | 1981 |
| ESBRIET267MG | 534MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 801MG · Tablet | Pirfenidone | United States | Marketed | 2017 |
| ESBRIET267mg · Capsule | Pirfenidone | United States | Marketed | 2014 |
| ETHYOL375mg/vial | 500mg/vial · Injectable | Amifostine | United States | Marketed | 1995 |
| IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 50MG · Tablet | Azathioprine | United States | Marketed | 1968 |
| LOTRONEX0.5mg base | 1mg base · Tablet | Alosetron | United States | Marketed | 2000 |
| MICORT-HC2.5% | 2% · Cream | Hydrocortisone | United States | Marketed | 2001 |
| MOTOFEN0.025mg; 1mg · Tablet | Atropine, Difenoxin | United States | Marketed | 1978 |
| MOTOFEN HALF-STRENGTH0.025mg; 0.5mg · Tablet | Atropine, Difenoxin | United States | Not marketed | 1978 |
| NAFTIN1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2% · Cream | Naftifine | United States | Marketed | 1988 |
| NAFTIN1% | 2% · GEL | Naftifine | United States | Marketed | 1990 |
| PRAMOSONE0.5%; 1% | 1%; 1% | 2.5%; 1% · Lotion | Hydrocortisone, Pramocaine | United States | Marketed | 1973 |
| PRAMOSONE0.5%; 1% | 1%; 1% · Cream | Hydrocortisone, Pramocaine | United States | Marketed | 1976 |
| RIDAURA3MG · Capsule | Auranofin | United States | Marketed | 1985 |
| ZANAFLEX2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 4MG BASE · Tablet | Tizanidine | United States | Marketed | 1996 |
| ZANAFLEX2mg base | 4mg base | 6mg base · Capsule | Tizanidine | United States | Marketed | 2002 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 21 | 21 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.